Simplex Trading’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $190K | Buy |
600
+100
| +20% | +$23.6K | ﹤0.01% | 4781 |
|
|
2026
Q1 | $99.8K | Buy |
+500
| New | +$98.9K | ﹤0.01% | 5092 |
|
|
2025
Q1 | – | Sell |
-2,400
| Closed | -$257K | – | 9128 |
|
|
2024
Q4 | $257K | Sell |
2,400
-4,100
| -63% | -$463K | ﹤0.01% | 4237 |
|
|
2024
Q3 | $650K | Sell |
6,500
-100
| -2% | -$10.1K | ﹤0.01% | 3312 |
|
|
2024
Q2 | $556K | Sell |
6,600
-10,100
| -60% | -$804K | ﹤0.01% | 3554 |
|
|
2024
Q1 | $1.22M | Buy |
16,700
+1,200
| +8% | +$88.5K | ﹤0.01% | 2905 |
|
|
2023
Q4 | $1.11M | Sell |
15,500
-200
| -1% | -$11.8K | ﹤0.01% | 2918 |
|
|
2023
Q3 | $940K | Buy |
15,700
+14,900
| +1,863% | +$981K | ﹤0.01% | 2730 |
|
|
2023
Q2 | $57K | Sell |
800
-100
| -11% | -$7.5K | ﹤0.01% | 5711 |
|
|
2023
Q1 | $51K | Buy |
+900
| New | +$64K | ﹤0.01% | 5901 |
|
|
2022
Q4 | – | Sell |
-1,603
| Closed | -$86K | – | 9846 |
|
|
2022
Q3 | $86K | Hold |
1,603
| – | – | ﹤0.01% | 5726 |
|
|
2022
Q2 | $89K | Buy |
1,603
+1,122
| +233% | +$63.7K | ﹤0.01% | 5723 |
|
|
2022
Q1 | $33K | Sell |
481
-7,694
| -94% | -$558K | ﹤0.01% | 7666 |
|
|
2021
Q4 | $787K | Sell |
8,175
-2,725
| -25% | -$252K | ﹤0.01% | 3199 |
|
|
2021
Q3 | $924K | Hold |
10,900
| – | – | ﹤0.01% | 3182 |
|
|
2021
Q2 | $892K | Buy |
10,900
+10,829
| +15,252% | +$901K | ﹤0.01% | 3284 |
|
|
2021
Q1 | $670K | Sell |
71
-86
| -55% | -$8.13K | ﹤0.01% | 2933 |
|
|
2020
Q4 | $974K | Buy |
157
+88
| +128% | +$5.02K | ﹤0.01% | 2595 |
|
|
2020
Q3 | $409K | Sell |
69
-228
| -77% | -$15.6K | ﹤0.01% | 3239 |
|
|
2020
Q2 | $2.07M | Buy |
297
+84
| +39% | +$5.33K | ﹤0.01% | 1480 |
|
|
2020
Q1 | $967K | Sell |
213
-484
| -69% | -$27.4K | ﹤0.01% | 1915 |
|
|
2019
Q4 | $4.54M | Buy |
697
+237
| +52% | +$15.8K | 0.01% | 865 |
|
|
2019
Q3 | $2.86M | Buy |
460
+266
| +137% | +$16.7K | 0.01% | 1057 |
|
|
2019
Q2 | $1.38M | Sell |
194
-207
| -52% | -$15.2K | ﹤0.01% | 1612 |
|
|
2019
Q1 | $3.14M | Buy |
401
+348
| +657% | +$26.4K | 0.01% | 1004 |
|
|
2018
Q4 | $447K | Buy |
53
+3
| +6% | +$320 | ﹤0.01% | 2336 |
|
|
2018
Q3 | $850K | Buy |
50
+42
| +525% | +$6.33K | ﹤0.01% | 2054 |
|
|
2018
Q2 | $103K | Sell |
8
-6,771
| -100% | -$756K | ﹤0.01% | 4253 |
|
|
2018
Q1 | $703K | Buy |
+6,779
| New | +$670K | 0.03% | 544 |
|
|
2017
Q3 | – | Sell |
-577
| Closed | -$196K | – | 6270 |
|
|
2017
Q2 | $196K | Buy |
+577
| New | +$40.4K | 0.01% | 1215 |
|
|
2017
Q1 | – | Sell |
-53
| Closed | -$3K | – | 6474 |
|
|
2016
Q4 | $3K | Sell |
53
-32
| -38% | -$2.02K | ﹤0.01% | 4751 |
|
|
2016
Q3 | $9K | Buy |
+85
| New | +$6.24K | ﹤0.01% | 3696 |
|
|
2015
Q3 | – | Sell |
-13
| Closed | -$5K | – | 5865 |
|
|
2015
Q2 | $5K | Sell |
13
-5
| -28% | -$273 | ﹤0.01% | 3659 |
|
|
2015
Q1 | $4K | Buy |
+18
| New | +$690 | ﹤0.01% | 3679 |
|
Other funds holding LGND
JT
CAM
Simplex Trading's LGND Position: Q2 2026 in Review
Simplex Trading opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,446 shares worth $457K. The stake represents ﹤0.01% of the portfolio and ranks #3718 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LGND as recently as Q4 2025.
Simplex Trading first reported a position in LGND in Q3 2015 and has held it in 23 quarters since. The position peaked at $669K in Q3 2018. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Simplex Trading held 1,446 shares of Ligand Pharmaceuticals worth $457K as of Q2 2026.
- Ligand Pharmaceuticals was a new Simplex Trading position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3718 holding.
- Simplex Trading first reported a position in Ligand Pharmaceuticals in Q3 2015 and has held it in 23 quarters since.
- Simplex Trading's Ligand Pharmaceuticals position peaked at $669K in Q3 2018.
- 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.